The Inexorable Rise Of Exscientia
Financings Bring In Half a Billion Dollars
The UK firm has not completed a clinical trial yet but having raised over $350m from its NASDAQ initial public offering and an extra $160m from a private placement, Exscientia's future looks extremely bright.
